Corporate Responsibility at Merck

Corporate Responsibility at Merck

For more than a century, Merck has been inventing medicines and vaccines for the world’s most challenging diseases. And today we’re continuing to invent new approaches that save and improve lives so that people can positively contribute to a healthier and more hopeful world.

Our corporate responsibility approach is aligned with the company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and wellbeing, developing and rewarding our employees, protecting the environment, and operating with the highest standards of ethics and transparency.

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.

Visit to learn more about Corporate Responsibility at Merck.

Content from this campaign

Merck Named to “Top 50 STEM Workplaces” for Native American Professionals 2018 List
Merck has been recognized as one of the Top 50 STEM Workplaces for Native American...
Jun 19, 2018 8:30 AM ET
Merck Named to Corporate Responsibility Magazine’s Annual 100 Best Corporate Citizens List
Corporate Responsibility Magazine has ranked Merck #22 on its 19th annual 100 Best Corporate Citizens list. The list recognizes the standout environmental, social and governance (ESG) performance of public companies across the United States. The 100 Best Corporate Citizens List documents 260 ESG data points of disclosure and performance measures—harvested from publicly...
May 10, 2018 8:20 AM ET
Project HOPE Names Merck Corporate Volunteer of the Year
Volunteers are often the unsung heroes of the quest to promote global health and respond to disasters, but without their contributions, millions of people in some of the world’s most challenged regions would be worse off.  In recognition of this crucial role, Project HOPE honored Jahn Moeller, a registered nurse from Queensland, Australia, as Volunteer of the Year, and Merck, as Corporate...
Apr 25, 2018 8:50 AM ET
Merck Commemorates 30 Years of MECTIZAN® Donation Program Progress
KENILWORTH, N.J., November 30, 2017 /3BL Media/ -- Today, Merck announced an expansion of the MECTIZAN® Donation Program (MDP) to reach up to an additional 100 million people per year through 2025 as part of the global effort to eliminate lymphatic filariasis (LF). Through the MDP, established by Merck in 1987, Merck donates MECTIZAN® (...
Nov 30, 2017 1:05 PM ET
Merck Publishes Annual Corporate Responsibility Report
KENILWORTH, N.J., November 2, 2017 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today published its 2016/2017 Corporate Responsibility Report. The report reflects the company’s performance in the areas of Access to Health, Employees, Environmental Sustainability and Ethics & Transparency...
Nov 2, 2017 9:30 AM ET